Safety and education during COVID-19: prevalence, associated factors and reopening plans of the School of Nursing
Seguridad y educación en COVID-19: prevalencia, factores asociados, planes de reapertura en una Facultad de Enfermería
Segurança e educação durante a COVID-19: prevalência, fatores associados e planos de reabertura da Faculdade de Enfermagem
Ricardo de Mattos Russo Rafael; Luiza Mara Correia; Alex Simões de Mello; Juliana Amaral Prata; Cristiane Helena Gallasch; Eugenio Fuentes Pérez Junior; Frances Valeria Costa e Silva; Lucia Helena Garcia Penna; Jaime Caravaca Morera; Karen Lucas Breda; Helena Maria Scherlowski Leal David
Abstract
Objective: to analyze the prevalence and factors associated with COVID-19 screening and propose the necessary strategies for the reopening of university Nursing Schools to face-to-face classes.
Methods: a cross-sectional study was designed from the baseline of a longitudinal Internet-based survey of a Brazilian School of Nursing. With the ordinal outcome (COVID-19 operational classification), data analysis was conducted using a multinomial regression model
Results: a total of 498 participants were included in the analysis and revealed 67.27% suspected and 11.65% confirmed cases of COVID-19. Wearing masks, public transportation, and being part of frontline healthcare workers were statistically associated with a positive history for COVID-19.
Conclusion: plans to reopen Nursing Schools must integrate the use of personal protective equipment, public transportation, and COVID-19 screening into education.
Keywords
Resumen
Palabras clave
Resumo
Objetivo: analisar a prevalência e os fatores associados à triagem da COVID-19 e propor as estratégias necessárias para a reabertura das Escolas de Enfermagem universitárias para as aulas presenciais.
Métodos: um estudo transversal foi projetado a partir da linha de base de uma pesquisa longitudinal baseada na Internet de uma Escola Brasileira de Enfermagem. Com o resultado ordinal (classificação operacional COVID-19), a análise de dados foi conduzida usando um modelo de regressão multinomial.
Resultados: um total de 498 participantes foi incluído na análise e revelou 67,27% de casos suspeitos e 11,65% de casos confirmados de COVID-19. O uso de máscaras, o transporte público e fazer parte da linha de frente dos trabalhadores da saúde foram estatisticamente associados a um histórico positivo para a COVID-19.
Conclusão: os planos de reabertura de Escolas de Enfermagem devem integrar o uso de equipamentos de proteção pessoal, o transporte público e a triagem da COVID-19 na educação.
Palavras-chave
References
1 World Health Organization. Rolling updates on coronavirus disease (COVID-19) [Internet]. Geneva: WHO; 2020 [cited 2020 Oct 2]. Available from:
2 World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. Geneva: WHO; 2020 [cited 2020 Oct 2]. Available from:
3 Rafael RMR, Neto M, de Carvalho MMB, David HMSL, Acioli S, Faria MGA. Epidemiology, public policies and covid-19 pandemics in Brazil: what can we expect? Rev Enferm. 2020;28:1-6.
4 Grassly NC, Pons-Salort M, Parker EPK, White PJ, Ferguson NM, Ainslie K et al. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Lancet Infect Dis. 2020;20(12):1381-1389.
5 Yu HJ, Hu YF, Liu X, Yao X, Wang Q, Liu L et al. Household infection: the predominant risk factor for close contacts of patients with COVID-19. Travel Med Infect Dis. 2020;36:101809.
6 McDonald CC. Reopening schools in the time of pandemic: look to the school nurses. J Sch Nurs. 2020;36(4):239-40.
7 Cooper DM, Guay-Woodford L, Blazar BR, Bowman S, Byington CL, Dome J et al. Reopening schools safely: the case for collaboration, constructive disruption of Pre-Coronavirus 2019 expectations, and creative solutions. J Pediatr. 2020;223:183-5.
8 Li A, Harries M, Ross LF. Reopening K-12 Schools in the Era of Coronavirus Disease 2019: Review of State-Level Guidance Addressing Equity Concerns. J Pediatr. 2020;227:38-44.e7.
9 Sheikh A, Sheikh A, Sheikh Z, Dhami S. Reopening schools after the COVID-19 lockdown. J Glob Health. 2020;10(1):1-3.
10 Viner RM, Bonell C, Drake L, Jourdan D, Davies N, Baltag V et al. Reopening schools during the COVID-19 pandemic: governments must balance the uncertainty and risks of reopening schools against the clear harms associated with prolonged closure. Arch Dis Child. 2021 fev;106(2):111-3.
11 The Lancet. COVID-19 in Brazil: “So what?”. Lancet. 2020;395(10235):1461.
12 Mian A, Khan S. Coronavirus: the spread of misinformation. BMC Med. 2020;18(1):18-9.
13 Silva LV, Harb MPAA, Santos AMTB, Teixeira CAM, Gomes VHM, Cardoso EHS et al. COVID-19 mortality underreporting in Brazil: analysis of data from government internet portals. J Med Internet Res. 2020;22(8):1-14.
14 Von-Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):1623-7.
15 Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):1-6.
16 Ministério da Saúde (BR). Protocolo de manejo clínico da Covid-19 na Atenção Especializada. Brasília: Ministério da Saúde; 2020.
17 StataCorp. Stata statistical software: release 15. Texas: StataCorp; 2017.
18 Comar M, Brumat M, Concas MP, Argentini G, Bianco AR, Bicego L et al. COVID-19 experience: first italian survey on healthcare staff members from a mother-child research hospital using combined molecular and rapid immunoassay tests. SSRN Electron J. 2020:1-12.
19 Flannery D, Gouma S, Dhudasia M, Mukhopadhyay S, Pfeifer M, Woodford E, et al. SARS-CoV-2 seroprevalence among parturient women. medRxiv. No prelo 2020.
20 Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jiménez A et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11(1):3500.
21 Jerković I, Ljubić T, Bašić Ž, Kružić I, Kunac N, Bezić J et al. SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Šibenik-Knin County, Croatia. J Occup Environ Med. 2021 jan 1;63(1):32-7.
22 Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313-9.
23 Amorim L Fo, Szwarcwald CL, Mateos SOG, Ponce de Leon ACM, Medronho RA, Veloso VG et al. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Rev Saude Publica. 2020;54:69.
24 Gomes CC, Cerutti C, Zandonade E, Maciel ELN, de Alencar FEC, Almada GL et al. A population-based study of the prevalence of COVID-19 infection in Espirito Santo, Brazil: methodology and results of the first stage. MedRxiv. 2020. http://dx.doi.org/10.1101/2020.06.13.20130559.
25 Hallal PC, Hartwig FP, Horta BL, Silveira MF, Struchiner CJ, Vidaletti LP et al. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Glob Heal. 2020;8(11):E1390-8.
26 Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535-44.
27 Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973-87.
28 Wang C, Pan R, Tang S, Ji JS, Shi X. Mask use during COVID-19: a risk adjusted strategy. Environ Pollut. 2020 Nov;266(Pt 1):115099.
29 Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5(9):e475-83.
30 Bampoe S, Lucas DN, Neall G, Sceales P, Aggarwal R, Caulfield K et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals. Anaesthesia. 2020;75(12):1614-9.
31 World Health Organization. Considerations for school-related public health measures in the context of COVID-19: annex to considerations in adjusting public health and social measures in the context of COVID-19. Geneva: WHO; 2020.
32 Rafael RMR, Neto M, Depret DG, Gil AC, Fonseca MHS, Souza-Santos R. Effect of income on the cumulative incidence of COVID-19: an ecological study. Rev Lat Am Enfermagem. 2020;28:e3344.
33 Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020;8(8):e1018-26.
34 Wenham C, Smith J, Morgan R, Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846-8.
35 Chattu VK, Yaya S. Emerging infectious diseases and outbreaks: Implications for women’s reproductive health and rights in resource-poor settings. Reprod Health. 2020;17(1):43.
36 Minayo MCS, Freire NP. Pandemia exacerba desigualdades na Saúde. Cien Saude Colet. 2020;25(9):3555-6.
37 Li R, Pei S, Chen B, Song Y, Zhang T, Yang W et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-93.
38 Manners C, Larios Bautista E, Sidoti H, Lopez OJ. Protective adaptive immunity against severe acute respiratory syndrome Coronaviruses 2 (SARS-CoV-2) and implications for vaccines. Cureus. 2020;12(6):e8399.
39 Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971-977.e3.
Submitted date:
12/12/2020
Accepted date:
03/17/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email